Moore Capital Management LP Lowers Stock Holdings in Chemed Corporation $CHE

Moore Capital Management LP decreased its stake in shares of Chemed Corporation (NYSE:CHE) by 51.2% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 5,072 shares of the company’s stock after selling 5,314 shares during the quarter. Moore Capital Management LP’s holdings in Chemed were worth $2,362,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Monetary Solutions Ltd acquired a new position in Chemed in the fourth quarter valued at $25,000. Los Angeles Capital Management LLC purchased a new position in shares of Chemed in the 4th quarter worth about $26,000. BOK Financial Private Wealth Inc. acquired a new position in shares of Chemed in the 4th quarter valued at about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Chemed during the 2nd quarter worth about $34,000. Finally, Versant Capital Management Inc grew its holdings in shares of Chemed by 7,500.0% during the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after purchasing an additional 75 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on CHE shares. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Wall Street Zen upgraded Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Oppenheimer raised their price objective on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research report on Friday, July 31st. Bank of America restated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Finally, Royal Bank Of Canada raised their target price on Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $530.75.

Chemed Price Performance

CHE opened at $518.26 on Tuesday. The company has a 50-day moving average of $511.08 and a 200-day moving average of $450.15. The company has a market capitalization of $6.77 billion, a P/E ratio of 26.03, a PEG ratio of 1.98 and a beta of 0.51. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $557.00. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million for the quarter, compared to the consensus estimate of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.Chemed’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the business posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities analysts expect that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be issued a $0.70 dividend. This is an increase from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Monday, August 17th. Chemed’s dividend payout ratio is 14.06%.

Insider Buying and Selling at Chemed

In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director directly owned 4,578 shares of the company’s stock, valued at $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Patrick P. Grace sold 190 shares of the firm’s stock in a transaction on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the sale, the director owned 3,533 shares in the company, valued at $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 6,537 shares of company stock worth $3,406,014. Insiders own 3.33% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.